These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29263305)

  • 21. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis.
    Yu J; Peng R; Chen H; Cui C; Ba J
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8146-53. PubMed ID: 23139279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy.
    Hoerster R; Fauser S; Cursiefen C; Kirchhof B; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1721-1725. PubMed ID: 28600710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.
    Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ
    Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision Medicine: Personalized Proteomics for the Diagnosis and Treatment of Idiopathic Inflammatory Disease.
    Velez G; Roybal CN; Colgan D; Tsang SH; Bassuk AG; Mahajan VB
    JAMA Ophthalmol; 2016 Apr; 134(4):444-8. PubMed ID: 26848019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
    Wei Q; Zhang T; Jiang R; Chang Q; Zhang Y; Huang X; Gao X; Jin H; Xu G
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5783-5791. PubMed ID: 29117316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy.
    La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F
    Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y; Gao S; Zhu Y; Shen X
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic analyses of the vitreous humour.
    Angi M; Kalirai H; Coupland SE; Damato BE; Semeraro F; Romano MR
    Mediators Inflamm; 2012; 2012():148039. PubMed ID: 22973072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placenta growth factor and vascular endothelial growth factor in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Tashimo A; Ohtsuka K; Mizue Y; Nishihira J
    Clin Exp Ophthalmol; 2005 Apr; 33(2):226-7. PubMed ID: 15807839
    [No Abstract]   [Full Text] [Related]  

  • 33. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF inhibitors and vitrectomy for diabetic vitreoretinopathy.
    Cury CE; Rodrigues EB; Meyer CH; Farah ME
    Dev Ophthalmol; 2009; 44():69-81. PubMed ID: 19494654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapies.
    Li Y; Busoy JM; Zaman BAA; Tan QSW; Tan GSW; Barathi VA; Cheung N; Wei JJ; Hunziker W; Hong W; Wong TY; Cheung CMG
    Exp Eye Res; 2018 Sep; 174():98-106. PubMed ID: 29852133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy.
    Yuuki T; Kanda T; Kimura Y; Kotajima N; Tamura J; Kobayashi I; Kishi S
    J Diabetes Complications; 2001; 15(5):257-9. PubMed ID: 11522500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface Area of Detachment, Proliferative Vitreoretinopathy, and Pulse Pressure, but not AGEs, are Associated With Retinal Redetachment.
    Fokkens BT; Mulder DJ; Nugteren MB; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6633-6638. PubMed ID: 27926755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.